Clinical trial
Arthralgia During Anastrozole Therapy for Breast Cancer
NCT00323479 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00323479 |
|---|---|
| Title | Arthralgia During Anastrozole Therapy for Breast Cancer |
| Official title | A Multicentre, Open Study Assessing Joint Disorders Under ARIMIDEX® (1mg/Day) as Adjuvant Treatment in Post Menopausal Women With Early Breast Cancer |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Early Breast Cancer |
| Intervention type | Drug |
| Interventions | Anastrozole |
| Enrollment | 114 |
| Start date | Jun 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | May 9, 2006 |
| Last update posted | Apr 6, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: